CompletedPhase 4NCT01974336
The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients
Studying Chronic intestinal failure
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Jinling Hospital, China
- Principal Investigator
- Wencheng Kong, MDNanjing University
- Intervention
- ursodeoxycholic acid(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2013 – 2016
Study locations (1)
- Jinling Hospital, Nanjing, Jiangsu, China
Collaborators
National Natural Science Foundation of China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01974336 on ClinicalTrials.govOther trials for Chronic intestinal failure
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNANCT06777251Changing the Future of Intestinal Failure in Intestinal Chronic Inflammation (INT-FAIL)Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- RECRUITINGNANCT07422792Anabolic Response To Intravenous Amino Acids In Chronic Intestinal Failure PatientsInstitute of Oncology Ljubljana
- RECRUITINGNCT04629014Prospective Multisite Study of Quality of Life in Pediatric Intestinal FailureBoston Children's Hospital